Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HealthCare Ventures

Founders Harold Werner

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 108
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 56
Rounds per year 2.77
Lead investments 12
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.48
Exits 33
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

HealthCare Ventures is the famous VC, which was founded in 1985. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Cambridge.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the HealthCare Ventures, startups are often financed by MPM Capital, Amgen Ventures, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Rho Ventures, Novartis Venture Fund, New Enterprise Associates. In the next rounds fund is usually obtained by Oxford Bioscience Partners, MPM Capital, Morgenthaler Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Genetics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Senseonics, Catalyst Biosciences, TetraLogic Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this HealthCare Ventures performs on 1 percentage points more the average number of lead investments. The top activity for fund was in 2011. The higher amount of exits for fund were in 2016. When the investment is from HealthCare Ventures the average startup value is 10-50 millions dollars.

The current fund was established by Harold Werner. We also calculated 6 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of HealthCare Ventures:
Typical Co-investors
HealthCare Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after HealthCare Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Proteostasis Therapeutics

Biotechnology
Medical
Therapeutics
$37M08 Sep 2015 Cambridge, Massachusetts, United States

Galleon Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$10M11 Jun 2015 Horsham Township, Pennsylvania, United States

Vaxxas

Biotechnology
Health Care
Medical Device
$25M10 Feb 2015 New South Wales

Colorescience

Beauty
Cosmetics
E-Commerce
Fashion
Lifestyle
$15M10 Sep 2014 Carlsbad, California, United States

Pathogenetix

Biotechnology
Genetics
Health Care
Health Diagnostics
$10M30 Oct 2013 Woburn, Massachusetts, United States

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$8M25 Mar 2013 Seattle, Washington, United States

Cleveland HeartLab

Biotechnology
Health Care
Life Science
Medical Device
$14M31 Oct 2012 Cleveland, Ohio, United States

Biotechnology
Life Science
01 Jan 2012 Cambridge, Massachusetts, United States

Mosaic Biosciences

Biotechnology
Medical
Therapeutics
$1M08 Nov 2011 Boulder, Colorado, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HealthCare Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 108
Average round size 23M
Rounds per year 2.77
Peak activity year 2011
Lead investments 12
Follow on index 0.48
Exits 33
Group Appearance index 0.92

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Proteostasis Therapeutics

Biotechnology
Medical
Therapeutics
$37M08 Sep 2015 Cambridge, Massachusetts, United States

Galleon Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$10M11 Jun 2015 Horsham Township, Pennsylvania, United States

Vaxxas

Biotechnology
Health Care
Medical Device
$25M10 Feb 2015 New South Wales

Colorescience

Beauty
Cosmetics
E-Commerce
Fashion
Lifestyle
$15M10 Sep 2014 Carlsbad, California, United States

Pathogenetix

Biotechnology
Genetics
Health Care
Health Diagnostics
$10M30 Oct 2013 Woburn, Massachusetts, United States

Theraclone Sciences

Biotechnology
Decision/Risk Analysis
Drug Delivery
Health Care
Medical
Therapeutics
$8M25 Mar 2013 Seattle, Washington, United States

Cleveland HeartLab

Biotechnology
Health Care
Life Science
Medical Device
$14M31 Oct 2012 Cleveland, Ohio, United States

Biotechnology
Life Science
01 Jan 2012 Cambridge, Massachusetts, United States

Mosaic Biosciences

Biotechnology
Medical
Therapeutics
$1M08 Nov 2011 Boulder, Colorado, United States
Crunchbase icon

Content report

The following text will be sent to our editors: